🟢 C4 Therapeutics Inc up 5.2% amid Goldman Sachs Healthcare Conference participation

C4 Therapeutics Inc is trading at $3.77 (5.2%) in pre-market amid management's participation in a major investor conference.

• The company is scheduled to participate in 1x1 investor meetings at the Goldman Sachs 47th Annual Global Healthcare Conference today, June 10, 2026.
• Investor focus at such events is typically on management's commentary regarding ongoing clinical programs, such as for its lead candidate cemsidomide, and the company's business development outlook.
• The move also extends a technical rebound after the stock experienced a steep pullback in early June.